| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/06/2001 | CA2617253A1 Synergistic agents for enhancing tissue repair |
| 12/06/2001 | CA2599562A1 Compounds for modulating the rage receptor |
| 12/06/2001 | CA2415470A1 Oil compositions comprising short, medium and long chain triglycerides and use thereof in reducing weight gain |
| 12/06/2001 | CA2413188A1 Petrolatum-based nose ointment |
| 12/06/2001 | CA2411666A1 Methods and compositions for producing a neurosalutary effect in a subject |
| 12/06/2001 | CA2411404A1 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 12/06/2001 | CA2411323A1 Il-8 receptor antagonists |
| 12/06/2001 | CA2411261A1 Use of ace inhibitors for treatment of patients suffering from behavioral disorders |
| 12/06/2001 | CA2410947A1 Methods for mediating gene suppresion by using factors that enhance rnai |
| 12/06/2001 | CA2410935A1 Novel polyamine analogues as therapeutic and diagnostic agents |
| 12/06/2001 | CA2410900A1 Compositions and methods for treating eye discomfort |
| 12/06/2001 | CA2410893A1 Compositions for enhancing therapeutic effects containing herbals and/or nutritional supplements and/or minerals and/or vitamins |
| 12/06/2001 | CA2410889A1 Naaladase inhibitors for treating retinal disorders and glaucoma |
| 12/06/2001 | CA2410886A1 Water-soluble amide derivatives of polyene macrolides and preparation and uses thereof |
| 12/06/2001 | CA2410882A1 Pharmaceutical composition containing at least a polymer associated or conjugated with at least a phenylalkylcarboxylic acid salt, conjugate polymers and uses thereof |
| 12/06/2001 | CA2410660A1 Cyclohexylamine derivatives as subtype selective nmda receptor antagonists |
| 12/06/2001 | CA2410655A1 Dihydropyridine compounds for the inhibition of calcium-influx |
| 12/06/2001 | CA2410650A1 Medicament for combating respiratory depression |
| 12/06/2001 | CA2410643A1 Hygromycin a derivatives for the treatment of bacterial and protozoal infections |
| 12/06/2001 | CA2410640A1 3-substituted isoquinolin-1-yl derivatives |
| 12/06/2001 | CA2410618A1 S-methyl-dihydro-ziprasidone for treatment of psychiatric disorders |
| 12/06/2001 | CA2410597A1 Melanocortin receptor agonists |
| 12/06/2001 | CA2410589A1 Pharmaceutical compositions of 2'-deoxy-2'-(fluoromethylene)cytidine |
| 12/06/2001 | CA2410516A1 Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers |
| 12/06/2001 | CA2410489A1 Human kcnq5 potassium channel, methods and compositions thereof |
| 12/06/2001 | CA2410475A1 Use of (di-substituted-phenyl)-pyrimidinyl-imidazole derivatives as jnk-inhibitors |
| 12/06/2001 | CA2410419A1 Improved methods of transfection |
| 12/06/2001 | CA2410265A1 Lyophilizable and enhanced compacted nucleic acids |
| 12/06/2001 | CA2410252A1 Diagnosis and treatment of herpes infections |
| 12/06/2001 | CA2409932A1 Combination of a mutant herpes virus and a chemotherapeutic agent for the treatment of cancer |
| 12/06/2001 | CA2409927A1 Combinations of an endothelin receptor antagonist and an antiepileptic compound having pain alleviating properties or analgesic |
| 12/06/2001 | CA2409871A1 Topical agent for dermatological use |
| 12/06/2001 | CA2409617A1 2,7-naphthyridine derivatives |
| 12/06/2001 | CA2409597A1 Protein kinase inhibitors |
| 12/06/2001 | CA2409359A1 Preparation of a pathogen inactivated solution of red blood cells having reduced immunogenicity |
| 12/06/2001 | CA2409188A1 Polyubiquitin based hydrogel and uses thereof |
| 12/06/2001 | CA2409006A1 Biciclic cyclohexylamines and their use as nmda receptor antogonists |
| 12/06/2001 | CA2408793A1 Use of a celecoxib composition for fast pain relief |
| 12/06/2001 | CA2408103A1 Tumor activated prodrug compounds and methods of making and using the same |
| 12/06/2001 | CA2406979A1 Indole derivatives with vascular damaging activity |
| 12/06/2001 | CA2380769A1 Transdermal delivery of lasofoxifene |
| 12/06/2001 | CA2380367A1 Compositions for providing zinc through oral administration |
| 12/05/2001 | EP1160325A1 Avermectin aglycon synthase genes |
| 12/05/2001 | EP1160252A1 Avermectin derivatives |
| 12/05/2001 | EP1160248A1 N-(Isoxazol-5-yl)-sulfonamide derivatives and their use as endothelin antagonists |
| 12/05/2001 | EP1160240A1 Guanylhydrazones for treating inflammatory conditions |
| 12/05/2001 | EP1160005A1 Nanoemulsion based on anionic polymers, and uses thereof especially in the cosmetic, dermatological, pharmaceutical and/or ophthalmic fields |
| 12/05/2001 | EP1159975A2 Anti-angiogenic compositions and methods of use |
| 12/05/2001 | EP1159974A1 Anti-angiogenic compositions and methods of use |
| 12/05/2001 | EP1159970A2 A pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss, comprising a nicotine receptor partial agonist and an anti-obesity agent |
| 12/05/2001 | EP1159966A2 Composition for the treatment of psoriasis |
| 12/05/2001 | EP1159965A2 Method of preventing or inhibiting fertilization |
| 12/05/2001 | EP1159964A2 Compositions and methods for stimulating gastrointestinal motility |
| 12/05/2001 | EP1159963A1 Composition for and method of preventing or treating breast cancer |
| 12/05/2001 | EP1159962A1 Liposome preparations |
| 12/05/2001 | EP1159961A2 Treatment of tumors with compounds having RxR retinoid receptor agonist activity |
| 12/05/2001 | EP1159960A1 Pharmaceutical compositions based on diclofenac |
| 12/05/2001 | EP1159959A1 Preventive for respiratory infectious diseases |
| 12/05/2001 | EP1159958A1 Vaseline-based nasal ointment |
| 12/05/2001 | EP1159952A1 Cosmetics |
| 12/05/2001 | EP1159941A2 Formulations for use in enzyme-orthokeratology |
| 12/05/2001 | EP1159756A2 Compounds for the treatment of cancer |
| 12/05/2001 | EP1159455A2 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE |
| 12/05/2001 | EP1159447A1 Methods for identifying compounds useful for inhibiting farnesyl diphosphate synthase |
| 12/05/2001 | EP1159431A2 Human kallikrein-like genes |
| 12/05/2001 | EP1159422A1 Compositions and methods for the treatment of tumors |
| 12/05/2001 | EP1159420A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides |
| 12/05/2001 | EP1159419A1 Promotion or inhibition of angiogenesis and cardiovascularization |
| 12/05/2001 | EP1159418A2 Muc-1 antagonists and methods of treating immune disorders |
| 12/05/2001 | EP1159387A1 Detergent compositions comprising photobleaching delivery systems |
| 12/05/2001 | EP1159354A1 A composition comprising a photo-oxidising agent and uses of the agent |
| 12/05/2001 | EP1159300A2 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith |
| 12/05/2001 | EP1159295A1 Method of purifying whey of lactic acid fermentation by electrodialysis |
| 12/05/2001 | EP1159291A1 C-terminal modified (n-substituted)-2-indolylcarbonyldipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 12/05/2001 | EP1159284A1 33 human secreted proteins |
| 12/05/2001 | EP1159280A2 Thiazoloindolinone compounds |
| 12/05/2001 | EP1159279A2 4-oxo-4,7-dihydro-thieno[2,3-b]pyridine-5-carboxamides as antiviral agents |
| 12/05/2001 | EP1159278A2 Inhibitors of aspartyl protease |
| 12/05/2001 | EP1159277A1 Crystal modification d of 8-cyano-1-cyclopropyl-7- (1s, 6s- 2,8- diazabicyclo- 4.3.0] nonan-8-yl) -6-fluoro -1,4-dihydro -4-oxo -3-quinoline carboxylic acid |
| 12/05/2001 | EP1159275A2 Imidazole compounds as histamine h3 ligands |
| 12/05/2001 | EP1159274A2 Method for the preparation of citalopram |
| 12/05/2001 | EP1159269A1 Anti-imflammatory indole derivatives |
| 12/05/2001 | EP1159267A1 N-substituted indolines as estrogenic agents |
| 12/05/2001 | EP1159265A1 C-16 unsaturated fp-selective prostaglandins analogs |
| 12/05/2001 | EP1159264A2 INHIBITORS OF FACTOR Xa |
| 12/05/2001 | EP1159263A1 Novel sulfonamide compounds and uses thereof |
| 12/05/2001 | EP1159262A1 Tyrosine alkoxyguanidines as integrin inhibitors |
| 12/05/2001 | EP1159261A2 Antizyme modulators and their use |
| 12/05/2001 | EP1159258A1 Amide compounds for the potentiation of cholinergic activity |
| 12/05/2001 | EP1159256A1 Sphingoid base derivatives and uses thereof |
| 12/05/2001 | EP1159237A1 Method of preparing surface-active alcohols and surface-active alcoholic ethers, products obtained by said method and their use |
| 12/05/2001 | EP1159061A1 Chemical method for making pyrithione particle dispersions |
| 12/05/2001 | EP1159010A1 Treatment of diarrhea caused by enteropathogenic escherichia coli |
| 12/05/2001 | EP1159009A2 Use of niaouli essential oil as transdermal permeation enhancer |
| 12/05/2001 | EP1159007A1 Use of gallic acid esters to increase bioavailability of orally administered pharmaceutical compounds |
| 12/05/2001 | EP1159006A2 Water-soluble compositions of bioactive lipophilic compounds |
| 12/05/2001 | EP1159005A1 Pharmaceutical combination of antiviral agents |
| 12/05/2001 | EP1159004A1 Novel redox clamping agents and uses thereof |
| 12/05/2001 | EP1158996A1 Novel amide derivatives as growth hormone secretagogues |
| 12/05/2001 | EP1158991A1 Treatment of asthma |